Neurology
Leica Microsystems, a world leader in microscopy and scientific instrumentation, has launched an evolved version of its ARveo 8 digital visualization micro...
January 29, 2024 | News
The company’s AI-enabled assessment tool leverages cutting-edge multimodal behavioral signal processing and machine learning to quantitatively captur...
January 26, 2024 | News
Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic developme...
January 24, 2024 | News
Relivion® is a novel, non-invasive multi-channel brain neuromodulation technology. It stands out by concurrently stimulating the occipital and tri...
January 12, 2024 | News
Evotec SE announced progress within the Company’s strategic partnership with Bristol Myers Squibb, further bolstering the joint pipeline of advanced ...
January 08, 2024 | News
Biocon Biologics, a unique, fully integrated, global biosimilars company with a rich portfolio of insulins and monoclonal antibodies, has successfully conc...
December 19, 2023 | News
This marks a significant milestone as XEOMIN® is the first approved neurotoxin for the treatment of this condition in the Australian market. Addit...
November 23, 2023 | News
Fujitsu Limited and Delight Health, a Bay Area startup, announced that Fujitsu will license its Topological Data Analysis (TDA) technology to Delight...
November 20, 2023 | News
Aquinnah Pharmaceuticals announced preclinical research findings for a novel therapeutic designed to slow or stop the progression of Alzheimer's disea...
October 31, 2023 | News
Clario's Precision Motion Opal® wearable sensor technology detects early Parkinson's disease (PD) progression in a Univ...
October 30, 2023 | News
PharmaKure, a clinical stage pharmaceutical company developing precision medicines for Alzheimer’s Disease and other neurodegenerative diseases...
October 25, 2023 | News
"As the first market in Asia, we are pleased to bring to Hong Kong this medication for migraine, as we understand how migraine can adversely...
October 02, 2023 | News
ATTUNE trial met its primary endpoint showing BNC210 treatment led to a statistically significant reduction in total PTSD symptom severity at 12 weeks. St...
September 29, 2023 | News
Cellectricon, a services provider dedicated to advancing neuroscience drug discovery, announced the launch of a new service module for neuroplasticit...
September 27, 2023 | News
Most Read
Bio Jobs
News